Cardiomyopathy and Exercise: Balancing Physical Activity with Heart Health

Paredes Karen^*
*Correspondence: Paredes Karen, Department of Internal Medicine, Antwerp University Hospital, 2650 Edegem, Belgium, Email:

Keywords

Cardiomyopathy • Exercise • Heart health

Introduction

Cardiomyopathy refers to a group of diseases that affect the heart muscle, impairing its ability to pump blood efficiently. This condition can lead to symptoms such as fatigue, shortness of breath, and swelling of the legs, and it poses an increased risk of complications like arrhythmias, heart failure, and sudden cardiac arrest. Despite these challenges, regular exercise remains an important component of maintaining overall health, including cardiovascular fitness. However, individuals with cardiomyopathy must navigate the delicate balance between reaping the benefits of physical activity and minimizing the potential risks to their compromised heart [1].

Literature Review

Physical activity offers numerous benefits for individuals with cardiomyopathy, including improved cardiovascular function, increased exercise tolerance, and enhanced quality of life. Regular exercise can help strengthen the heart muscle, improve circulation, and reduce the risk of developing comorbidities such as obesity, hypertension, and diabetes. Additionally, exercise has been shown to alleviate symptoms of depression and anxiety commonly associated with chronic illnesses, promoting mental well-being. Despite the potential advantages, exercise also poses certain risks for individuals with cardiomyopathy. Vigorous or uncontrolled physical activity can strain the already weakened heart muscle, leading to arrhythmias, myocardial ischemia, or sudden cardiac events. Furthermore, some forms of exercise, such as high-intensity training or competitive sports, may be particularly hazardous for individuals with certain types of cardiomyopathy, such as Hypertrophic Cardiomyopathy (HCM), due to the inc reased risk of sudden cardiac death [2].

Discussion

Given the complexities of cardiomyopathy, it is essential for individuals to consult with their healthcare providers before initiating or modifying an exercise regimen. A tailored approach to exercise prescription, based on individualized assessments of cardiac function, symptomatology, and exercise capacity, is crucial for optimizing safety and efficacy. Prior to starting an exercise program, individuals should undergo a comprehensive evaluation by a healthcare professional experienced in managing cardiac conditions. This evaluation may include a physical examination, Electrocardiogram (ECG), echocardiogram, and exercise stress testing to assess cardiac function and identify any potential contraindications to exercise [3].

Exercise recommendations should be tailored to the specific needs and limitations of each individual, taking into account factors such as the type and severity of cardiomyopathy, presence of symptoms, and overall health status. A combination of aerobic exercise, such as walking, cycling, or swimming, and resistance training may be prescribed to improve cardiovascular fitness, muscle strength, and endurance gradually. Regular monitoring of exercise intensity, duration, and frequency is essential for gauging tolerance and adjusting the exercise prescription as needed. Individuals should be encouraged to listen to their bodies and report any new or worsening symptoms, such as chest pain, palpitations, dizziness, or shortness of breath, to their healthcare providers promptly. Exercise progression should be gradual and guided by objective measures of cardiac function and exercise tolerance [4]. Risk stratification is crucial for identifying individuals at higher risk of adverse events during exercise and implementing appropriate risk-reduction strategies. Factors such as the presence of ventricular arrhythmias, severe left ventricular dysfunction, or a history of sudden cardiac events may necessitate more conservative exercise recommendations or restrictions on certain activities. In addition to regular exercise, individuals with cardiomyopathy should adopt a hearthealthy lifestyle that includes maintaining a balanced diet, managing stress, avoiding tobacco and excessive alcohol consumption, and ensuring adequate rest and recovery. These lifestyle modifications can complement the benefits of exercise and contribute to long-term cardiovascular health [5].

Despite advancements in our understanding of cardiomyopathy and exercise, several areas warrant further investigation. Research efforts could focus on elucidating the optimal exercise prescription for different subtypes of cardiomyopathy, including hypertrophic, dilated, and restrictive cardiomyopathy, considering their distinct pathophysiological mechanisms and clinical presentations. Longitudinal studies are needed to assess the long-term effects of exercise on cardiac function, symptom progression, and clinical outcomes in individuals with cardiomyopathy. Additionally, the role of emerging modalities such as cardiac rehabilitation, telemedicine, and wearable technologies in supporting exercise adherence and monitoring in this population merits exploration [6].

Conclusion

The relationship between cardiomyopathy and exercise is complex, requiring a balanced approach to promote cardiovascular health while minimizing the risk of adverse events. While exercise holds significant potential benefits for individuals with cardiomyopathy, including improved cardiac function, exercise tolerance, and quality of life, it must be tailored to the individual's specific condition and guided by evidence-based guidelines. Through collaborative efforts among patients, healthcare providers, researchers, and community stakeholders, we can advance our understanding of the role of exercise in cardiomyopathy and promote optimal heart health for all individuals living with this condition.

Acknowledgement

None.

Conflict of Interest

None.

References

1. Li, Jing, Bradley Richmond, and TingTing Hong. “Cardiac T-Tubule cBIN1-microdomain, a diagnostic marker and therapeutic target of heart failure.”Int J Mol Sci22 (2021): 2299.

   Google Scholar, Crossref, Indexed at

2. Nikolova, Andriana P., Tara C. Hitzeman, Rachel Baum and Ana-Maria Caldaruse, et al. “Association of a novel diagnostic biomarker, the plasma cardiac bridging integrator 1 score, with heart failure with preserved ejection fraction and cardiovascular hospitalization.”JAMA Cardiol3 (2018): 1206-1210.

   Google Scholar, Crossref, Indexed at

3. Hong, Ting-Ting, Rebecca Cogswell, Cynthia A. James and Guson Kang, et al. “Plasma BIN1 correlates with heart failure and predicts arrhythmia in patients with arrhythmogenic right ventricular cardiomyopathy.”Heart Rhythm9 (2012): 961-967.

   Google Scholar, Crossref, Indexed at

4. Lipsett, David Bruce, Michael Frisk, Jan Magnus Aronsen and Einar Sjaastad Norden, et al. “Cardiomyocyte substructure reverts to an immature phenotype during heart failure.”J Physiol597 (2019): 1833-1853.

   Google Scholar, Crossref, Indexed at

5. Frisk, Michael, Marianne Ruud, Emil KS Espe and Jan Magnus Aronsen, et al. “Elevated ventricular wall stress disrupts cardiomyocyte t-tubule structure and calcium homeostasis.”Cardiovasc Res112 (2016): 443-451.

   Google Scholar, Crossref, Indexed at

6. Bai, Jian, Na Zhang, Ying Hua and Bingjian Wang, et al. “Metformin inhibits angiotensin II-induced differentiation of cardiac fibroblasts into myofibroblasts.”PloS one8 (2013): e72120.

   Google Scholar, Crossref, Indexed at